Advertisement

Glaucomatous Versus Nonglaucomatous Visual Loss: The Neuro-Ophthalmic Perspective

  • Matthew D. Kay
  • Mark L. Moster
  • Paul N. Schacknow
Chapter

Abstract

The diagnosis of glaucoma is generally straightforward in the setting of elevated intraocular pressure (IOP), glaucomatous excavation of the disc, and characteristic nerve fiber bundle defects on visual field testing. However, one should always carry an index of suspicion for an alternative nonglaucomatous process and critically evaluate the optic nerves and visual fields. Is the degree of visual loss consistent with the optic nerve changes? Is the character of the visual field loss compatible with glaucomatous change? Are additional investigations warranted, and if so, what studies should be performed?

Keywords

Optic Nerve Optic Neuropathy Visual Field Defect Central Retinal Vein Occlusion Visual Field Loss 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Levin L. Neurobiologic rationale for neuroprotection. In: Weinreb RN, ed. Glaucoma Neuroprotection. Philadelphia: Wolters Kluwer Health; 2006:1–7.Google Scholar
  2. 2.
    Takada M, Araie M, Suzuki Y, Koseki N, Yamagami J. The central visual field defects in low-tension glaucoma. A comparison of the central visual field defects in low-tension glaucoma with those in primary open angle glaucoma. Nippon Ganka Gakkai Zasshi. 1993;97(11):1320–1324.PubMedGoogle Scholar
  3. 3.
    Araie M, Yamagami J, Suziki Y. Visual field defects in normal-tension and high-tension glaucoma. Ophthalmology. 1993;100(12):1808–1814.PubMedGoogle Scholar
  4. 4.
    Quigley HA, Vitale S. Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci. 1997;38(1):83–91.PubMedGoogle Scholar
  5. 5.
    Klein BE, Klein R, Sponsel WE, et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology. 1992;99(10):1499–1504.Google Scholar
  6. 6.
    Quigley HA, West SK, Rodriguez J, Munoz B, Klein R, Snyder R. The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol. 2001;119(12):1819–1826.PubMedGoogle Scholar
  7. 7.
    Bonomi L, Marchini G, Marraffa M, et al. Prevalence of glaucoma and intraocular pressure distribution in a defined population. The Egna-Neumarkt Study. Ophthalmology. 1998;105(2):209–215.Google Scholar
  8. 8.
    Varma R, Ying-Lai M, Francis BA, et al. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2004;111(8):1439–1448.CrossRefPubMedGoogle Scholar
  9. 9.
    Beck RW, Savino PJ, Repka MX, Schatz NJ, Sergott RC. Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology. 1984;91(11):1334–7.PubMedGoogle Scholar
  10. 10.
    Sebag J, Thomas JV, Epstein DL, Grant WM. Optic disc cupping in arteritic anterior ischemic optic neuropathy resembles glaucomatous cupping. Ophthalmology. 1986;93(3):357–361.PubMedGoogle Scholar
  11. 11.
    Danesh-Meyer HV, Savino PJ, Sergott RC. The prevalence of cupping in end-stage arteritic and nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2001;108(3):593–598.CrossRefPubMedGoogle Scholar
  12. 12.
    Hayreh SS, Jonas JB. Optic disc morphology after arteritic anterior ischemic optic neuropathy. Ophthalmology. 2001;108(9):1586–1594.CrossRefPubMedGoogle Scholar
  13. 13.
    Trobe JD, Glaser JS, Cassady J, Herschler J, Anderson DR. Nonglaucomatous excavation of the optic disc. Arch Ophthalmol. 1980;98(6):1046–1050.PubMedGoogle Scholar
  14. 14.
    Rebolleda G, Noval S, Contreras I, Arnalich-Montiel F, Garcia-Perez JL, Munoz-Negrete FJ. Optic disc cupping after optic neuritis evaluated with optic coherence tomography. Eye. 2009;23(4):890–894Google Scholar
  15. 15.
    Fournier AV, Damji KF, Epstein DL, Pollock SC. Disc excavation in dominant optic atrophy: differentiation from normal tension glaucoma. Ophthalmology. 2001;108(9):1595–1602.CrossRefPubMedGoogle Scholar
  16. 16.
    Trobe JD, Glaser JS, Cassady JC. Optic atrophy. Differential diagnosis by fundus observation alone. Arch Ophthalmol. 1980;98(6):1040–1045.Google Scholar
  17. 17.
    Bianchi-Marzoli S, Rizzo JF 3rd, Brancato R, Lessell S. Quantitative analysis of optic disc cupping in compressive optic neuropathy. Ophthalmology. 1995;102(3):436–440.PubMedGoogle Scholar
  18. 18.
    Brown RH, Zilis JD, Lynch MG, Sanborn GE. The afferent pupillary defect in asymmetric glaucoma. Arch Ophthalmol. 1987;105(11):1540–1543.PubMedGoogle Scholar
  19. 19.
    Lankaranian D, Altangerel U, Spaeth GL, Leavitt JA, Steinmann WC. The usefulness of a new method of testing for a relative afferent pupillary defect in patients with ocular hypertension and glaucoma. Trans Am Ophthalmol Soc. 2005;103:200-207; discussion 207–208.Google Scholar
  20. 20.
    Wall M, Hart WM Jr, Burde RM. Visual field defects in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 1983;96(5):654–669.PubMedGoogle Scholar
  21. 21.
    Savino PJ, Glaser JS, Rosenberg MA. A clinical analysis of pseudopapilledema. II. Visual field defects. Arch Ophthalmol. 1979;97(1):71–75.Google Scholar
  22. 22.
    Dorrell D. The tilted disc. Br J Ophthalmol. 1978;62(1):16–20.CrossRefPubMedGoogle Scholar
  23. 23.
    Hart WM Jr, Becker B. The onset and evolution of glaucomatous visual field defects. Ophthalmology. 1982;89(3):268–279.PubMedGoogle Scholar
  24. 24.
    Healey PR, Mitchell P, Smith W, Wang JJ. Optic disc hemorrhages in a population with and without signs of glaucoma. Ophthalmology. 1998;105(2):216–223.CrossRefPubMedGoogle Scholar
  25. 25.
    Greenfield DS, Siatkowski RM, Glaser JS, Schatz NJ, Parrish RK, 2nd. The cupped disc. Who needs neuroimaging? Ophthalmology. 1998;105(10):1866–1874.Google Scholar
  26. 26.
    Moster ML. Detection and treatment of optic nerve sheath meningioma. Curr Neurol Neurosci Rep. 2005;5(5):367–75.CrossRefPubMedGoogle Scholar
  27. 27.
    Varma R, Spaeth GL, Katz LJ, Feldman RM. Collateral vessel formation in the optic disc in glaucoma. Arch Ophthalmol. 1987;105(9):1287.PubMedGoogle Scholar
  28. 28.
    Kupersmith MJ, Krohn D. Cupping of the optic disc with compressive lesions of the anterior visual pathway. Ann Ophthalmol. 1984;16(10):948–953.PubMedGoogle Scholar
  29. 29.
    Ellis J. Risk Management Issues in Failure to Diagnose Neurologic Illness. Omic Digest; 1994.Google Scholar
  30. 30.
    Lundstrom M, Frisen L. Evolution of descending optic atrophy. A case report. Acta Ophthalmol (Copenh). 1975;53(5):738–746.Google Scholar
  31. 31.
    Newman NJ. Perioperative visual loss after nonocular surgeries. Am J Ophthalmol. 2008;145(4):604–610.CrossRefPubMedGoogle Scholar
  32. 32.
    Kline LB, Glaser JS. Dominant optic atrophy. The clinical profile. Arch Ophthalmol. 1979;97(9):1680–1686.Google Scholar
  33. 33.
    Votruba M, Thiselton D, Bhattacharya SS. Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy. Br J Ophthalmol. 2003;87(1):48–53.CrossRefPubMedGoogle Scholar
  34. 34.
    Werner E. Low tension glaucoma. In: Ritch R, Shields M, Krupin T, eds. The Glaucomas. Mosby: St. Louis;1989:804.Google Scholar
  35. 35.
    Mashima Y, Kimura I, Yamamoto Y, et al. Optic disc excavation in the atrophic stage of Leber’s hereditary optic neuropathy: comparison with normal tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 2003;241(2):75–80.Google Scholar
  36. 36.
    Ortiz RG, Newman NJ, Manoukian SV, Diesenhouse MC, Lott MT, Wallace DC. Optic disk cupping and electrocardiographic abnormalities in an American pedigree with Leber’s hereditary optic neuropathy. Am J Ophthalmol. 1992;113(5):561–566.Google Scholar
  37. 37.
    Bayer AU, Ferrari F, Erb C. High occurrence rate of glaucoma among patients with Alzheimer’s disease. Eur Neurol. 2002;47(3):165–168.CrossRefPubMedGoogle Scholar
  38. 38.
    Tsai CS, Ritch R, Schwartz B, et al. Optic nerve head and nerve fiber layer in Alzheimer’s disease. Arch Ophthalmol. 1991;109(2):199–204.PubMedGoogle Scholar
  39. 39.
    Kessing LV, Lopez AG, Andersen PK, Kessing SV. No increased risk of developing Alzheimer disease in patients with glaucoma. J Glaucoma. 2007;16(1):47–51.CrossRefPubMedGoogle Scholar
  40. 40.
    Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer’s disease. Neurosci Lett. 2007;420(2):97–99.Google Scholar
  41. 41.
    Parisi V. Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer’s disease. Semin Ophthalmol. 2003;18(2):50–57.PubMedGoogle Scholar
  42. 42.
    Parisi V, Restuccia R, Fattapposta F, Mina C, Bucci MG, Pierelli F. Morphological and functional retinal impairment in Alzheimer’s disease patients. Clin Neurophysiol. 2001;112(10):1860–1867.CrossRefPubMedGoogle Scholar
  43. 43.
    Iseri PK, Altinas O, Tokay T, Yuksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol. 2006;26(1):18–24.PubMedGoogle Scholar
  44. 44.
    Friberg TR, Weinreb RN. Ocular manifestations of gravity inversion. JAMA. 1985;253(12):1755–1757.Google Scholar
  45. 45.
    Slamovits T. Popping eyes. Surv Ophthalmol. 1989;33(4):273–280.Google Scholar
  46. 46.
    Pecora L, Sibony P, Fourman S. Eye-rubbing optic neuropathy. Am J Ophthalmol. 2002;134(3):460–461.CrossRefPubMedGoogle Scholar
  47. 47.
    Schuman JS, Massicotte EC, Connolly S, Hertzmark E, Mukherji B, Kunen MZ. Increased intraocular pressure and visual field defects in high resistance wind instrument players. Ophthalmology. 2000;107(1):127–133.CrossRefPubMedGoogle Scholar
  48. 48.
    Chromiak JA, Abadie BR, Braswell RA, Koh YS, Chilek DR. Resistance training exercises acutely reduce intraocular pressure in physically active men and women. J Strength Cond Res. 2003;17(4):715–720.PubMedGoogle Scholar
  49. 49.
    Schargus M, Gramer E. IOP-lowering therapy prevents visual field progression in patients with optic disc drusen, poster 560, page 248. American Academy of Opthalmology. Las Vegas, NV; 2006.Google Scholar
  50. 50.
    Grippo TM, Shihadeh WA, Schargus M, et al. Optic nerve head drusen and visual field loss in normotensive and hypertensive eyes. J Glaucoma. 2008;17(2):100–104.CrossRefPubMedGoogle Scholar
  51. 51.
    Greenfield DS. Measuring neuroprotection in glaucoma clinical trials. In: Weinreb RN, ed. Glaucoma Neuroprotection. Philadelphia: Wolters Kluwer Health; 2006:73–81.Google Scholar
  52. 52.
    Wilhelm B, Ludtke H, Wilhelm H. Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial. Graefes Arch Clin Exp Ophthalmol. 2006;244(5):551–558.Google Scholar
  53. 53.
    Kim TW, Kim DM, Park KH, Kim H. Neuroprotective effect of memantine in a rabbit model of optic nerve ischemia. Korean J Ophthalmol. 2002;16(1):1–7.PubMedGoogle Scholar
  54. 54.
    WoldeMussie E, Yoles E, Schwartz M, Ruiz G, Wheeler LA. Neuroprotective effect of memantine in different retinal injury models in rats. J Glaucoma. 2002;11(6):474–480.CrossRefPubMedGoogle Scholar
  55. 55.
    Levin LA, Peeples P. History of neuroprotection and rationale as a therapy for glaucoma. Am J Manag Care. 2008;14(1 Suppl):S11–14.PubMedGoogle Scholar
  56. 56.
    Yucel YH, Gupta N, Zhang Q, Mizisin AP, Kalichman MW, Weinreb RN. Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma. Arch Ophthalmol. 2006;124(2):217–225.CrossRefPubMedGoogle Scholar
  57. 57.
    Stuart A. Glaucoma neuroprotection research, part 2. EyeNet. 2008:29–31.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Matthew D. Kay
    • 1
  • Mark L. Moster
    • 2
  • Paul N. Schacknow
    • 3
    • 4
  1. 1.Neuro-ophthalmologist, Private PracticeWest Palm BeachUSA
  2. 2.Jefferson Medical College, Neuro-Ophthalmology Service, Wills Eye InstituteElkins ParkUSA
  3. 3.Nova Southeastern UniversityFort LauderdaleUSA
  4. 4.Visual Health CenterPalm SpringsUSA

Personalised recommendations